Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours
Sign Up to like & getrecommendations! Published in 2022 at "Neuropathology and Applied Neurobiology"
DOI: 10.1111/nan.12813
Abstract: Rosette‐forming glioneuronal tumour (RGNT) is a rare central nervous system (CNS) World Health Organization (WHO) grade 1 brain neoplasm. According to the WHO 2021, essential diagnostic criteria are a ‘biphasic histomorphology with neurocytic and a… read more here.
Keywords: tumours midline; fgfr1 mutated; midline fgfr1; glioneuronal tumours ... See more keywords